IP Verse

Seagen competitive analysis

Loading summary...

Latest patents of Seagen opposed by its competitors

Explore Seagen's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025

Patent Number	Grant Date	Title	Total Oppositions
EP3464368	Jun 28, 2023	Use Of An Anti-Pd-1 Antibody In Combination With An Anti-Cd30 Antibody In Lymphoma Treatment	1
EP3057585	Jul 22, 2020	Pegylated Drug-Linkers For Improved Ligand-Drug Conjugate Pharmacokinetics	1

Latest publications and patents of Seagen New

Explore the latest publications and patents granted to Seagen, showcasing their recent innovations and technological advancements.

Last updated on: Oct 22, 2025

Publication Number	Publication Date	Title	Legal Status
Get instant update for new patents of Seagen
EP3464368	Jun 28, 2023	Use Of An Anti-Pd-1 Antibody In Combination With An Anti-Cd30 Antibody In Lymphoma Treatment	Granted And Under Opposition
EP3057585	Jul 22, 2020	Pegylated Drug-Linkers For Improved Ligand-Drug Conjugate Pharmacokinetics	Granted And Under Opposition

Latest PTAB cases involving Seagen

Discover the latest PTAB cases involving Seagen, highlighting their recent legal challenges and patent disputes.

Last updated on: Oct 28, 2025

Proceeding Number	Filing Date	Petitioner	Respondent	Status
Get alerts for PTAB Cases involving Seagen
PGR2021-00042	Jan 22, 2021	DAIICHI SANKYO	SEAGEN	Terminated-Adverse Judgment
PGR2021-00030	Dec 23, 2020	DAIICHI SANKYO	SEAGEN	Final Written Decision - Appealed

Peer Comparison New

IP litigation analysis comparing Seagen with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
SEAGEN	-	2	-	2
DAIICHI SANKYO	-	4	3	7
EUROPEAN OPPOSITIONS	30	-	-	-
STRAWMAN	336	-	-	-